Don't know about the VLA comment but there are too many possibilities and up to 7 main targets in cancer along if the iMYC program is successful. There is plenty of good, thoughtful stuff on the threads if you want the real answers - and plenty of healthy sceptisism from holders as well. If you want the reason not to bother than just read my recent links to the vocal critic from about 12-18 months ago.
The recent news was Genetech biologics USD2m payment (first of $142m potential excluding royalties) - this is targetting superbugs.
PYC Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)